Evidence map›Paper›PMID 25092293›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.

Andrew E Armitage, Andrea R Stacey, Eleni Giannoulatou, Elizabeth Marshall, Pamela Sturges, Kamaljit Chatha, Nicola M G Smith, XiaoJie Huang, XiaoNing Xu, Sant-Rayn Pasricha and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Anemia, Iron Status, and HIV: A Systematic Review of the Evidence.Advances in nutrition (Bethesda, Md.) · 2020
    Pooled it
  2. A hepcidin homolog fromVirulence · 2026
    Article
  3. Iron and the immune system.Nature reviews. Immunology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. [Ferroptosis and liver diseases].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Can iron chelators ameliorate viral infections?Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Iron as a therapeutic target in chronic liver disease.World journal of gastroenterology · 2023
    Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Andrew E ArmitageMedical Research Council (MRC) Human Immunology Unit and.
Andrea R StaceyNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom;
Eleni GiannoulatouComputational Biology Research Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom;
Elizabeth MarshallNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom;
Pamela SturgesDepartment of Biochemistry, Birmingham Heartlands Hospital, Birmingham B9 5SS, United Kingdom;
Kamaljit ChathaDepartment of Biochemistry, Birmingham Heartlands Hospital, Birmingham B9 5SS, United Kingdom;
Nicola M G SmithNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom;
XiaoJie HuangCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China;
XiaoNing XuDepartment of Medicine, Imperial College, Chelsea and Westminster Hospital, London SW10 9NH, United Kingdom;
Sant-Rayn PasrichaMedical Research Council (MRC) Human Immunology Unit and.
Ning LiCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China;
Hao WuCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China;
Craig WebsterDepartment of Biochemistry, Birmingham Heartlands Hospital, Birmingham B9 5SS, United Kingdom;
Andrew M PrenticeMRC International Nutrition Group, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom;
Pierre PellegrinoCentre for Sexual Health and HIV Research, Mortimer Market Centre, University College London, London WC1 6JB, United Kingdom;
Ian WilliamsCentre for Sexual Health and HIV Research, Mortimer Market Centre, University College London, London WC1 6JB, United Kingdom;
Phillip J NorrisBlood Systems Research Institute, San Francisco, CA 94118; andDepartments of Laboratory Medicine andMedicine, University of California, San Francisco, CA 94143.ORCID http://orcid.org/0000-0003-0526-2088
Hal DrakesmithMedical Research Council (MRC) Human Immunology Unit and hdrakes@hammer.imm.ox.ac.uk persephone.borrow@ndm.ox.ac.uk.
Persephone BorrowNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; hdrakes@hammer.imm.ox.ac.uk persephone.borrow@ndm.ox.ac.uk.
University of Oxford · GBHeartlands Hospital · GBCapital Medical University · CNMortimer Market Centre · GBMRC Human Immunology Unit · GBBeijing YouAn Hospital · CNChelsea and Westminster Hospital · GBLondon School of Hygiene & Tropical Medicine · GBMedical Research Council · GBUniversity of California, San Francisco · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2006 to 2011
$290.5M
Medical Research Council G0700844Medical Research Council MC-A760-5QX00Medical Research Council MC_U123292699Medical Research Council MC_UU_12010/10Medical Research Council MRC G0700844Medical Research Council MR/K012037/1NIAID NIH HHS U19 AI067854
6 · The paper itself

Abstract

During HIV type-1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus (HBV) infections, altered iron balance correlates with morbidity. The liver-produced hormone hepcidin dictates systemic iron homeostasis. We measured hepcidin, iron parameters, cytokines, and inflammatory markers in three cohorts: plasma donors who developed acute HIV-1, HBV, or HCV viremia during the course of donations; HIV-1-positive individuals progressing from early to chronic infection; and chronically HIV-1-infected individuals (receiving antiretroviral therapy or untreated). Hepcidin increased and plasma iron decreased during acute HIV-1 infection, as viremia was initially detected. In patients transitioning from early to chronic HIV-1 infection, hepcidin in the first 60 d of infection positively correlated with the later plasma viral load set-point. Hepcidin remained elevated in individuals with untreated chronic HIV-1 infection and in subjects on ART. In contrast to HIV-1, there was no evidence of hepcidin up-regulation or hypoferremia during the primary viremic phases of HCV or HBV infection; serum iron marginally increased during acute HBV infection. In conclusion, hepcidin induction is part of the pathogenically important systemic inflammatory cascade triggered during HIV-1 infection and may contribute to the establishment and maintenance of viral set-point, which is a strong predictor of progression to AIDS and death. However, distinct patterns of hepcidin and iron regulation occur during different viral infections that have particular tissue tropisms and elicit different systemic inflammatory responses. The hypoferremia of acute infection is therefore a pathogen-specific, not universal, phenomenon.

Indexed as

Acute-Phase ProteinsAnti-HIV AgentsCohort StudiesCytokinesHepatitis BHepatitis CHepcidinsHIV-1HIV InfectionsIronUp-RegulationViral LoadAcute-Phase ProteinsAnti-HIV AgentsCytokinesHepcidinsIron

Identifiers

PMID25092293
PMCPMC4142992
OpenAlexW2049741486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.